...
首页> 外文期刊>Journal of neurointerventional surgery >Endovascular recanalization of complete subacute to chronic atherosclerotic occlusions of intracranial arteries
【24h】

Endovascular recanalization of complete subacute to chronic atherosclerotic occlusions of intracranial arteries

机译:完全亚急性颅内动脉慢性动脉粥样硬化闭塞的血管内再通

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective/background: Symptomatic subacute/chronic large artery intracranial occlusive disease represents a common medical dilemma. We now report a multicenter experience of endovascular recanalization of intracranial atherosclerotic occlusions refractory to medical therapy. Methods: Retrospective multicenter case series of consecutive endovascularly treated patients presenting with symptomatic (transient ischemic attack (TIA) or stroke) subacute (>48 h) or chronic complete occlusion of an intracranial artery of presumed atherosclerotic etiology. All of the patients were considered to be in the high risk category with symptomatic intracranial occlusions and progression or recurrence of their symptoms despite the best medical therapies. Results: 24 patients (median age 63 years; mean pretreatment National Institutes of Health Stroke Scale (NIHSS) score 10; 66% men) presenting with recurrent TIAs (n=1) or strokes (n=23) were treated in two academic centers from April 2005 to June 2012. Median time from symptoms/documented occlusion to treatment was 5 days. Periprocedural complications included one symptomatic intracranial hemorrhage, one reperfusion syndrome, three asymptomatic dissections, and one asymptomatic perforation. There were no periprocedural strokes. Immediate postprocedural improvement (NIHSS decrease ≤4 at hospital discharge) occurred in 43% (10/23) of patients. There were no recurrent TIAs or strokes in the 22 patients with clinical follow-up at 90 days. At 90 days, there were two deaths (unrelated to the procedure) and 9/22 patients with an available modified Rankin Scale (mRS) score achieved a good outcome (mRS score of 0-2). Conclusions: Endovascular recanalization can be performed with an acceptable safety profile in selected patients with symptomatic complete subacute to chronic intracranial atherosclerotic occlusion. Additional studies are warranted to investigate whether this treatment compares favorably with best medical management.
机译:目的/背景:有症状的亚急性/慢性大动脉颅内阻塞性疾病是常见的医学难题。我们现在报告对药物治疗难治的颅内动脉粥样硬化闭塞的血管内再通的多中心经验。方法:回顾性多中心病例系列病例,这些病例连续出现症状(短暂性脑缺血发作(TIA)或中风)亚急性(> 48小时)或颅内动脉慢性完全闭塞,其病因推测为动脉粥样硬化。尽管有最佳的药物治疗方法,但所有患者均被认为属于有症状的颅内阻塞,症状发展或复发的高危人群。结果:在两个学术中心治疗了24例复发性TIA(n = 1)或中风(n = 23)的患者(中位年龄63岁;美国国立卫生研究院卒中平均评分(NIHSS)平均预处理评分10; 66%的男性)从2005年4月到2012年6月。从出现症状/记录到阻塞到治疗的中位时间为5天。围手术期并发症包括1例有症状的颅内出血,1例再灌注综合征,3例无症状的夹层和1例无症状的穿孔。没有围手术期中风。 43%(10/23)的患者出现了术后即时改善(出院时NIHSS降低≤4)。在90天的临床随访中,这22例患者没有再发TIA或中风。在90天时,有2例死亡(与手术无关),已有9/22例改良的Rankin量表(mRS)评分的患者取得了良好的预后(mRS评分为0-2)。结论:对于有症状的完全亚急性至慢性颅内动脉粥样硬化闭塞的选定患者,可以进行安全性可接受的血管内再通。有必要进行其他研究,以调查这种治疗方法是否与最佳医疗管理方法相媲美。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号